Zwi Vromen

Directeur/Membre du Conseil chez Agan Chemicals Ltd.

Profil

Zwi Vromen, Senior Partner Mr. Vromen has served as the Vice President of Business Development at Koor Chemicals, a Director on the Board of Tambour Ltd., Agan Chemicals Ltd., as well as the Joint Managing Director of Plantex and Ikapharm (Koor's pharmaceutical ventures).
Mr. Vromen has also acted as a management consultant to Teva Pharmaceutical Industries Ltd.
and BioTechnology General Ltd., two of Israel's leading pharmaceutical and biotechnology companies.
Since 1993, Mr. Vromen has acted as the General Manager of SBRC Ltd., which is the Management Company of the Astra Fund ($10 M) and since 1996 he is an active member of the Board of Directors of the First IsraTech Fund.
The Astra Portfolio Companies include medical equipment, biotechnology, communications and agricultural firms.
The First IsraTech Fund ($14 M) has invested in Israeli and Israeli related high technology companies, in the medical and industrial fields.
Mr. Vromen holds a B.Sc.
degree in Chemical Engineering from Imperial College (London, UK) as well as a business diploma from the Hebrew University of Jerusalem.

Postes actifs de Zwi Vromen

Sociétés	Poste	Début
Millennium Materials Fund Management Co. Ltd.	Private Equity Investor	-
Koor Chemicals Ltd.	Corporate Officer/Principal	14/03/2011
Agan Chemicals Ltd.	Directeur/Membre du Conseil	14/03/2011
Plantex Ltd.	Corporate Officer/Principal	14/03/2011
Ikapharm Ltd.	Corporate Officer/Principal	14/03/2011

Anciens postes connus de Zwi Vromen

Sociétés	Poste	Fin
Terra Venture Management Ltd.	Membre du Comité d'Investissement	01/01/2011
SOL-GEL TECHNOLOGIES LTD.	Directeur/Membre du Conseil	-
Medivie Therapeutic Ltd.	Directeur/Membre du Conseil	-

Formation de Zwi Vromen

Imperial College London

Undergraduate Degree